CVE-2018-17538
Axon Evidence Sync vulnerability
Axon (formerly TASER International) Evidence Sync 3.15.89 is vulnerable to process injection. NOTE: the vendor's position is that this CVE is not associated with information that supports any finding of any type of vulnerability
High priority: this vulnerability is rated critical and can be attacked over the network without a login.
Affected products
Evidence Sync. The exact versions are in the references.
What to do now
- Check your exposureFind out whether Axon Evidence Sync runs anywhere in your environment, including systems of suppliers.
- UpdateInstall the version in which the vendor fixed the vulnerability. The references lead to the advisory.
- Limit access until thenIf you cannot update at once, take the system off the internet or restrict who can reach it.
References
- github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Review_Report.pdf · Exploit
- github.com/GitHubAssessments/CVE_Assessment_05_2018/blob/master/Evidence_Sync_Report.pdf · Exploit
- raw.githubusercontent.com/GitHubAssessments/CVE_Assessment_05_2018/master/Evidence_Sync_Re · Exploit
- nvd.nist.gov/vuln/detail/CVE-2018-17538
- cve.org/CVERecord?id=CVE-2018-17538
Data: CVE list and the NVD. This product uses data from the NVD API but is not endorsed or certified by the NVD.